Literature DB >> 15876450

The inflammatory response to vaccination is altered in the elderly.

Mimoun El Yousfi1, Sabine Mercier, Denis Breuillé, Philippe Denis, Isabelle Papet, Philippe Patureau Mirand, Christiane Obled.   

Abstract

To further explore whether immune function and acute phase response are altered during ageing, the response to a mild inflammatory stress (DT-Polio-Typhim vaccination) was studied in elderly and young subjects. Cytokine production (IFN-gamma, TNF-alpha, IL-6, IL-10) by whole blood cultures, circulating cytokines and acute phase proteins were analysed before and 2 days after vaccination. Prior to vaccination, only IFN-gamma production was lower in the elderly than in the young subjects due to a lower mononuclear cell number. In the same time, although in the normal range, several acute phase proteins were greater in elderly than in young subjects, suggesting a low-grade inflammatory state in the elderly. After vaccination, IFN-gamma production remained lower in the elderly than in the young, supporting an altered cell-mediated immunity with advancing age. TNF-alpha production was unaffected by either ageing or vaccination. IL-6 production was stimulated by vaccination in young subjects but not significantly in the elderly. IL-10 production was inhibited by vaccination in the elderly but not in the young. Acute phase proteins were less increased in elderly than in young subjects. Taken together, these results support a general lack of inflammatory response in the elderly exposed to an immune challenge and suggest that immune deficiency may concern both Th1 and Th2 responses. However, the interpretation must respect the limitation of small subjects number.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15876450     DOI: 10.1016/j.mad.2005.03.008

Source DB:  PubMed          Journal:  Mech Ageing Dev        ISSN: 0047-6374            Impact factor:   5.432


  19 in total

1.  Positive antibody response to vaccination in adolescence predicts lower C-reactive protein concentration in young adulthood in the Philippines.

Authors:  Thomas W McDade; Linda Adair; Alan B Feranil; Christopher Kuzawa
Journal:  Am J Hum Biol       Date:  2010-12-17       Impact factor: 1.937

2.  C-reactive protein response to influenza vaccination as a model of mild inflammatory stimulation in the Philippines.

Authors:  Thomas W McDade; Judith B Borja; Christopher W Kuzawa; Tita Lorna L Perez; Linda S Adair
Journal:  Vaccine       Date:  2015-03-18       Impact factor: 3.641

3.  No influence of atopic diseases on antibody titres following tetanus, diphtheria and hepatitis B immunisation among adults.

Authors:  N Friedrich; A Kramer; R Mentel; L Gürtler; U John; H Völzke
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-12       Impact factor: 3.267

Review 4.  Vaccination in the elderly: an immunological perspective.

Authors:  Wilbur H Chen; Bernard F Kozlovsky; Rita B Effros; Beatrix Grubeck-Loebenstein; Robert Edelman; Marcelo B Sztein
Journal:  Trends Immunol       Date:  2009-06-18       Impact factor: 16.687

Review 5.  A brief, highly selective history of acute phase proteins as indicators of infection, inflammation and injury.

Authors:  Michael C Powanda; Elizabeth D Moyer
Journal:  Inflammopharmacology       Date:  2021-05-21       Impact factor: 4.473

6.  Transcriptomic biomarkers of the response of hospitalized geriatric patients with infectious diseases.

Authors:  Thi Kim Duy Vo; Patrice Godard; Marie de Saint-Hubert; Gabriel Morrhaye; Christian Swine; Vincent Geenen; Henri J Martens; Florence Debacq-Chainiaux; Olivier Toussaint
Journal:  Immun Ageing       Date:  2010-08-17       Impact factor: 6.400

Review 7.  Non-specific immunological effects of selected routine childhood immunisations: systematic review.

Authors:  Rama Kandasamy; Merryn Voysey; Fiona McQuaid; Karlijn de Nie; Rebecca Ryan; Olivia Orr; Ulrike Uhlig; Charles Sande; Daniel O'Connor; Andrew J Pollard
Journal:  BMJ       Date:  2016-10-13

Review 8.  Immunological outcomes of exercise in older adults.

Authors:  David S Senchina; Marian L Kohut
Journal:  Clin Interv Aging       Date:  2007       Impact factor: 4.458

Review 9.  Safety Profile of the Adjuvanted Recombinant Zoster Vaccine in Immunocompromised Populations: An Overview of Six Trials.

Authors:  Marta López-Fauqued; Maribel Co-van der Mee; Adriana Bastidas; Pierre Beukelaers; Alemnew F Dagnew; Juan Jose Fernandez Garcia; Anne Schuind; Fernanda Tavares-da-Silva
Journal:  Drug Saf       Date:  2021-06-11       Impact factor: 5.606

10.  Relationship between systemic inflammation and delayed-type hypersensitivity response to Candida antigen in older adults.

Authors:  Brandt D Pence; Thomas W Lowder; K Todd Keylock; Victoria J Vieira Potter; Marc D Cook; Edward McAuley; Jeffrey A Woods
Journal:  PLoS One       Date:  2012-05-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.